DSE:SQURPHARMA Statistics

Total Valuation

DSE:SQURPHARMA has a market cap or net worth of BDT 192.09 billion. The enterprise value is 125.65 billion.

Market Cap	192.09B
Enterprise Value	125.65B

Important Dates

The last earnings date was Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Nov 24, 2024

Share Statistics

DSE:SQURPHARMA has 886.45 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	886.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	35.97%
Owned by Institutions (%)	4.45%
Float	567.55M

Valuation Ratios

The trailing PE ratio is 8.59 and the forward PE ratio is 8.46.

PE Ratio	8.59
Forward PE	8.46
PS Ratio	2.66
PB Ratio	1.49
P/TBV Ratio	1.49
P/FCF Ratio	30.35
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.42, with an EV/FCF ratio of 19.85.

EV / Earnings	5.62
EV / Sales	1.74
EV / EBITDA	5.42
EV / EBIT	6.00
EV / FCF	19.85

Financial Position

The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.01.

Current Ratio	5.10
Quick Ratio	4.03
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.18
Interest Coverage	65.10

Financial Efficiency

Return on equity (ROE) is 18.19% and return on invested capital (ROIC) is 8.88%.

Return on Equity (ROE)	18.19%
Return on Assets (ROA)	7.85%
Return on Invested Capital (ROIC)	8.88%
Return on Capital Employed (ROCE)	13.59%
Revenue Per Employee	5.80M
Profits Per Employee	1.80M
Employee Count	12,453
Asset Turnover	0.51
Inventory Turnover	2.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.32% in the last 52 weeks. The beta is 0.24, so DSE:SQURPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-0.32%
50-Day Moving Average	216.02
200-Day Moving Average	217.71
Relative Strength Index (RSI)	48.86
Average Volume (20 Days)	206,298

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SQURPHARMA had revenue of BDT 72.27 billion and earned 22.38 billion in profits. Earnings per share was 25.24.

Revenue	72.27B
Gross Profit	32.46B
Operating Income	17.68B
Pretax Income	26.47B
Net Income	22.38B
EBITDA	19.92B
EBIT	17.68B
Earnings Per Share (EPS)	25.24

Full Income Statement

Balance Sheet

The company has 57.75 billion in cash and 1.13 billion in debt, giving a net cash position of 66.45 billion or 74.96 per share.

Cash & Cash Equivalents	57.75B
Total Debt	1.13B
Net Cash	66.45B
Net Cash Per Share	74.96
Equity (Book Value)	129.00B
Book Value Per Share	145.52
Working Capital	63.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.12 billion and capital expenditures -6.79 billion, giving a free cash flow of 6.33 billion.

Operating Cash Flow	13.12B
Capital Expenditures	-6.79B
Free Cash Flow	6.33B
FCF Per Share	7.14

Full Cash Flow Statement

Margins

Gross margin is 44.91%, with operating and profit margins of 24.46% and 30.96%.

Gross Margin	44.91%
Operating Margin	24.46%
Pretax Margin	36.64%
Profit Margin	30.96%
EBITDA Margin	27.57%
EBIT Margin	24.46%
FCF Margin	8.76%

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 5.08%.

Dividend Per Share	11.00
Dividend Yield	5.08%
Dividend Growth (YoY)	4.76%
Years of Dividend Growth	7
Payout Ratio	41.27%
Buyback Yield	n/a
Shareholder Yield	5.08%
Earnings Yield	11.65%
FCF Yield	3.30%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SQURPHARMA has an Altman Z-Score of 9.53.

Altman Z-Score	9.53
Piotroski F-Score	n/a